People with multiple sclerosis (MS) may receive less frequent treatments with anti-CD20 therapies without increasing their risk of disease activity or disability progression. That’s according to a new meta-analysis of published studies that investigated the use of different dosing schedules for anti-CD20 therapies — approved treatments that deplete the…
Read more
Psychological testing indicates that I’m not crazy, but when I share some of the things I’ve done in the Army, people sometimes wonder. I never say that I’m not, because that’s what a crazy person would say. Instead, I provide a three-point answer: One, would I even know? Two,…
Doctors will be able to diagnose multiple sclerosis (MS) faster and with greater accuracy — allowing patients to access treatment and support earlier — following an update to the McDonald criteria, the official guidelines used to diagnose the condition. The revision reflects advances in understanding the biology of…
An international research team has secured nearly $800,000 (about CA$1.1 million) to advance a potential regenerative therapy for multiple sclerosis (MS) toward clinical testing. While existing treatments can slow disease progression, none can repair the nerve damage that has already occurred. This new project aims to change that by…
Life with multiple sclerosis (MS) is unpredictable, involving many unknowns. Symptoms can come and go, flare up without warning, and affect every aspect of our health, from movement to memory. Managing MS is already a full-time job, and the added weight of life’s uncertainties often makes it even more…
Get regular updates to your inbox.
